BMO Capital Markets Increases HCA Healthcare (HCA) Price Target to $155.00

Share on StockTwits

HCA Healthcare (NYSE:HCA) had its target price increased by equities researchers at BMO Capital Markets from $145.00 to $155.00 in a report issued on Wednesday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the stock. BMO Capital Markets’ target price indicates a potential upside of 17.16% from the stock’s current price.

HCA has been the topic of a number of other reports. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare to $151.00 and gave the company an “overweight” rating in a research report on Monday, July 30th. SunTrust Banks boosted their price target on shares of HCA Healthcare to $150.00 and gave the company a “positive” rating in a research report on Tuesday. Mizuho restated a “buy” rating and issued a $145.00 price target on shares of HCA Healthcare in a research report on Thursday, August 2nd. Leerink Swann boosted their price target on shares of HCA Healthcare from $125.00 to $140.00 and gave the company an “outperform” rating in a research report on Thursday, July 26th. Finally, Piper Jaffray Companies restated a “hold” rating and issued a $124.00 price target on shares of HCA Healthcare in a research report on Thursday, July 26th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $123.05.

NYSE:HCA opened at $132.30 on Wednesday. The stock has a market capitalization of $46.30 billion, a price-to-earnings ratio of 20.08, a PEG ratio of 1.21 and a beta of 0.54. HCA Healthcare has a 12 month low of $71.18 and a 12 month high of $138.18. The company has a current ratio of 1.36, a quick ratio of 1.15 and a debt-to-equity ratio of -7.64.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, beating the Zacks’ consensus estimate of $2.16 by $0.13. The firm had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.73 earnings per share. research analysts predict that HCA Healthcare will post 9.23 earnings per share for the current fiscal year.

In other news, insider Jonathan B. Perlin sold 25,000 shares of the company’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $106.00, for a total transaction of $2,650,000.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Victor L. Campbell sold 22,782 shares of the company’s stock in a transaction that occurred on Friday, August 3rd. The stock was sold at an average price of $127.12, for a total transaction of $2,896,047.84. Following the transaction, the senior vice president now owns 202,650 shares in the company, valued at $25,760,868. The disclosure for this sale can be found here. Insiders have sold 209,507 shares of company stock worth $25,305,075 over the last quarter. 2.80% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently bought and sold shares of HCA. FMR LLC raised its stake in shares of HCA Healthcare by 54.9% during the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after buying an additional 1,944,961 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of HCA Healthcare by 187.9% during the second quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock worth $112,289,000 after buying an additional 714,331 shares during the last quarter. LSV Asset Management raised its stake in shares of HCA Healthcare by 9.2% during the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after buying an additional 457,752 shares during the last quarter. Millennium Management LLC raised its stake in shares of HCA Healthcare by 32.3% during the second quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock worth $174,270,000 after buying an additional 414,877 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA raised its stake in shares of HCA Healthcare by 62.6% during the second quarter. Massachusetts Financial Services Co. MA now owns 891,489 shares of the company’s stock worth $91,466,000 after buying an additional 343,121 shares during the last quarter. 70.40% of the stock is owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: How Do You Make Money With Penny Stocks?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply